161 related articles for article (PubMed ID: 36593250)
21. Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early-stage tongue squamous cell carcinoma.
Xie N; Wang C; Liu X; Li R; Hou J; Chen X; Huang H
J Oral Pathol Med; 2015 Apr; 44(4):266-72. PubMed ID: 25169851
[TBL] [Abstract][Full Text] [Related]
22. TERT promoter mutation in patients with second primary of tongue squamous cell carcinoma.
Erkul E; Yilmaz I
Oral Oncol; 2021 Mar; 114():105089. PubMed ID: 33189577
[TBL] [Abstract][Full Text] [Related]
23. Four PTEN-targeting co-expressed miRNAs and ACTN4- targeting miR-548b are independent prognostic biomarkers in human squamous cell carcinoma of the oral tongue.
Berania I; Cardin GB; Clément I; Guertin L; Ayad T; Bissada E; Nguyen-Tan PF; Filion E; Guilmette J; Gologan O; Soulieres D; Rodier F; Wong P; Christopoulos A
Int J Cancer; 2017 Dec; 141(11):2318-2328. PubMed ID: 28779483
[TBL] [Abstract][Full Text] [Related]
24. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
[TBL] [Abstract][Full Text] [Related]
25. LMX1B mRNA expression and its gene body CpG methylation are valuable prognostic biomarkers for laryngeal squamous cell carcinoma.
Fan L; Zhang A; Deng P
Biomed Pharmacother; 2019 Sep; 117():109174. PubMed ID: 31387183
[TBL] [Abstract][Full Text] [Related]
26. A three-lncRNA expression signature predicts survival in head and neck squamous cell carcinoma (HNSCC).
Wang P; Jin M; Sun CH; Yang L; Li YS; Wang X; Sun YN; Tian LL; Liu M
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30355656
[TBL] [Abstract][Full Text] [Related]
27. Guanylate-binding protein 6 is a novel biomarker for tumorigenesis and prognosis in tongue squamous cell carcinoma.
Liu PF; Chen HC; Shu CW; Sie HC; Lee CH; Liou HH; Cheng JT; Tsai KW; Ger LP
Clin Oral Investig; 2020 Aug; 24(8):2673-2682. PubMed ID: 31707626
[TBL] [Abstract][Full Text] [Related]
28. Appraising Oncogenic Long Noncoding RNAs as Novel Biomarkers for Oral Tongue Squamous Cell Carcinoma: a Meta-Analysis.
Cheng Y; Wang Y; Cui Z; Lin D; Zheng M; Cheng H
Clin Lab; 2019 Sep; 65(9):. PubMed ID: 31532111
[TBL] [Abstract][Full Text] [Related]
29. Deep learning-based model for predicting progression in patients with head and neck squamous cell carcinoma.
Zhao Z; Li Y; Wu Y; Chen R
Cancer Biomark; 2020; 27(1):19-28. PubMed ID: 31658045
[TBL] [Abstract][Full Text] [Related]
30. A PIK3CA transgenic mouse model with chemical carcinogen exposure mimics human oral tongue tumorigenesis.
Tan MT; Wu JG; Callejas-Valera JL; Schwarz RA; Gillenwater AM; Richards-Kortum RR; Vigneswaran N
Int J Exp Pathol; 2020 Feb; 101(1-2):45-54. PubMed ID: 32436348
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of lncRNA HOTTIP Suppresses the Proliferation, Migration, and Invasion of Oral Tongue Squamous Cell Carcinoma by Regulation of HMGA2-Mediated Wnt/β-Catenin Pathway.
Xiong L; Tang Y; Tang J; Liu Z; Wang X
Cancer Biother Radiopharm; 2020 Nov; 35(9):720-730. PubMed ID: 31910357
[No Abstract] [Full Text] [Related]
32. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Zhu W; Ye Z; Chen L; Liang H; Cai Q
Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
[TBL] [Abstract][Full Text] [Related]
33. High immune cytolytic activity in tumor-free tongue tissue confers better prognosis in patients with squamous cell carcinoma of the oral tongue.
Gu X; Boldrup L; Coates PJ; Fahraeus R; Wang L; Wilms T; Norberg-Spaak L; Sgaramella N; Nylander K
J Pathol Clin Res; 2019 Oct; 5(4):240-247. PubMed ID: 31237113
[TBL] [Abstract][Full Text] [Related]
34.
Akagi Y; Tachibana T; Orita Y; Gion Y; Marunaka H; Makino T; Miki K; Akisada N; Yoshino T; Nishizaki K; Sato Y
Acta Otolaryngol; 2019 Jul; 139(7):647-651. PubMed ID: 31066593
[No Abstract] [Full Text] [Related]
35. Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma.
Habu N; Imanishi Y; Kameyama K; Shimoda M; Tokumaru Y; Sakamoto K; Fujii R; Shigetomi S; Otsuka K; Sato Y; Watanabe Y; Ozawa H; Tomita T; Fujii M; Ogawa K
BMC Cancer; 2015 Oct; 15():730. PubMed ID: 26483189
[TBL] [Abstract][Full Text] [Related]
36. Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma.
Chen L; He X; Yi S; Liu G; Liu Y; Ling Y
Biomed Res Int; 2021; 2021():8824195. PubMed ID: 33628816
[TBL] [Abstract][Full Text] [Related]
37. LncRNA LTSCCAT promotes tongue squamous cell carcinoma metastasis via targeting the miR-103a-2-5p/SMYD3/TWIST1 axis.
Liu M; Liu Q; Fan S; Su F; Jiang C; Cai G; Wang Y; Liao G; Lei X; Chen W; Bi J; Cheng W; Zhao L; Ruan Y; Li J
Cell Death Dis; 2021 Feb; 12(2):144. PubMed ID: 33542221
[TBL] [Abstract][Full Text] [Related]
38. Genomic and epigenetic characterization for the comparison of synchronous bilateral tongue squamous cell carcinomas-A case report.
Ribeiro IP; Barroso L; Marques F; Santos A; Caramelo F; Julião MJ; Melo JB; Carreira IM
Curr Probl Cancer; 2017; 41(6):398-406. PubMed ID: 29056289
[TBL] [Abstract][Full Text] [Related]
39. A molecular signature of well-differentiated oral squamous cell carcinoma reveals a resistance mechanism to metronomic chemotherapy and novel therapeutic candidates.
Kina S; Kawabata-Iwakawa R; Miyamoto S; Arasaki A; Sunakawa H; Kinjo T
J Drug Target; 2021 Dec; 29(10):1118-1127. PubMed ID: 33979258
[TBL] [Abstract][Full Text] [Related]
40. Altered mRNA Expression of Genes Involved in Endocannabinoid Signalling in Squamous Cell Carcinoma of the Oral Tongue.
Alhouayek M; Boldrup L; Fowler CJ
Cancer Invest; 2019; 37(8):327-338. PubMed ID: 31423851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]